| Ident. | Authors (with country if any) | Title |
|---|
| 000061 |
M. Konno ; T. Haseqawa ; T. Baba | Selective Serotonin Reuptake Inhibitors Emerge as the Therapeutic Agent for Synucleinopathies |
| 000067 |
Benedicte Ballanger [France] ; Helene Klinger [France] ; Julien Eche [France] ; Jerome Lerond [France] ; Anne-Evelyne Vallet [France] ; Didier Le Bars [France] ; Leon Tremblay [France] ; Véronique Sgambato-Faure [France] ; Emmanuel Broussolle [France] ; Stéphane Thobois [France] | Role of Serotonergic 1A Receptor Dysfunction in Depression Associated with Parkinson's Disease |
| 000162 |
Philippe Huot [Canada] ; Tom H. Johnston [Canada] ; Naomi P. Visanji [Canada] ; Tayyeba Darr [Canada] ; Donna Pires [Canada] ; Lili-Naz Hazrati [Canada] ; Jonathan M. Brotchie [Canada] ; Susan H. Fox [Canada] | Increased Levels of 5-HT1A Receptor Binding in Ventral Visual Pathways in Parkinson's Disease |
| 000361 |
Klaus Seppi ; Daniel Weintraub ; Miguel Coelho ; Santiago Perez-Lloret ; Susan H. Fox ; Regina Katzenschlager ; Eva-Maria Hametner ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; Christopher G. Goetz ; Cristina Sampaio | The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the Non-Motor Symptoms of Parkinson's Disease |
| 000851 |
Manolo Carta [Suède] ; Thomas Carlsson [Suède] ; Ana Munoz [Suède] ; Deniz Kirik [Suède] ; Anders Björklund [Suède] | Role of Serotonin Neurons in the Induction of Levodopa- and Graft-Induced Dyskinesias in Parkinson's Disease |
| 000A06 |
Philippe Huot [Canada] ; Tom H. Johnston [Canada] ; Tayyeba Darr [Canada] ; Lili-Naz Hazrati [Canada] ; Naomi P. Visanji [Canada] ; Donna Pires [Canada] ; Jonathan M. Brotchie [Canada] ; Susan H. Fox [Canada] | Increased 5-HT2A Receptors in the Temporal Cortex of Parkinsonian Patients with Visual Hallucinations |
| 000D05 |
Susan H. Fox [Canada] ; Rosalind Chuang [Canada] ; Jonathan M. Brotchie [Canada] | Serotonin and Parkinson's Disease: On Movement, Mood, and Madness |
| 000D86 |
Maria Stamelou [Allemagne] ; Andreas Matusch [Allemagne] ; David Elmenhorst [Allemagne] ; René Hurlemann [Allemagne] ; Karla M. Eggert [Allemagne] ; Karl Zilles [Allemagne] ; Wolfgang H. Oertel [Allemagne] ; Günter U. Höglinger [Allemagne] ; Andreas Bauer [Allemagne] | Nigrostriatal Upregulation of 5-HT2A Receptors Correlates with Motor Dysfunction in Progressive Supranuclear Palsy |
| 001316 |
David Devos [France] ; Kathy Dujardin [France] ; Isabelle Poirot [France] ; Caroline Moreau [France] ; Olivier Cottencin [France] ; Pierre Thomas [France] ; Alain Destée [France] ; Regis Bordet [France] ; Luc Defebvre [France] | Comparison of Desipramine and Citalopram Treatments for Depression in Parkinson's Disease : A Double-Blind, Randomized, Placebo-Controlled Study |
| 001751 |
Paul T. Francis [Royaume-Uni] ; Elaine K. Perry [Royaume-Uni] | Cholinergic and Other Neurotransmitter Mechanisms in Parkinson's Disease, Parkinson's Disease Dementia, and Dementia with Lewy Bodies |
| 001819 |
Michael Behen [États-Unis] ; Harry T. Chugani [États-Unis] ; Csaba Juhasz [États-Unis] ; Emily Helder [États-Unis] ; Albert Ho [États-Unis] ; Mohsin Maqbool [États-Unis] ; Robert D. Rothermel [États-Unis] ; Jacquie Perry [États-Unis] ; Otto Muzik [États-Unis] | Abnormal Brain Tryptophan Metabolism and Clinical Correlates in Tourette Syndrome |
| 001D93 |
ZHI LIU [Japon] ; Ryuji Sakakibara [Japon] ; Takeo Odaka [Japon] ; Tomoyuki Uchiyama [Japon] ; Tomoyuki Uchiyama [Japon] ; Tatsuya Yamamoto [Japon] ; Takashi Ito [Japon] ; Masato Asahina [Japon] ; Kazuya Yamaguchi [Japon] ; Taketo Yamaguchi [Japon] ; Takamichi Hattori [Japon] | Mosapride citrate, a novel 5-HT4 agonist and partial 5-HT3 antagonist, ameliorates constipation in Parkinsonian patients |
| 001E63 |
William Bara-Jimenez [États-Unis] ; Francesco Bibbiani [États-Unis] ; Michael J. Morris [États-Unis] ; Tzvetelina Dimitrova [États-Unis] ; Abdullah Sherzai [États-Unis] ; Maral M. Mouradian [États-Unis] ; Thomas N. Chase [États-Unis] | Effects of serotonin 5-HT1A agonist in advanced Parkinson's disease |
| 002239 |
Sebastian Paus [Allemagne] ; Gert Seeger [Allemagne] ; Hans M. Brecht [Allemagne] ; Jürgen Köster [Allemagne] ; Mahha El-Faddagh [Allemagne] ; Markus M. Nöthen [Belgique] ; Thomas Klockgether [Allemagne] ; Ullrich Wüllner [Allemagne] | Association study of dopamine D2, D3, D4 receptor and serotonin transporter gene polymorphisms with sleep attacks in Parkinson's disease |
| 002574 |
| Treatment of depression in idiopathic Parkinson's disease |
| 002850 |
David J. Burn [Royaume-Uni] | Beyond the iron mask: Towards better recognition and treatment of depression associated with Parkinson's disease |
| 002873 |
Tarja H. Haapaniemi [Finlande] ; Aapo Ahonen [Finlande] ; Pentti Tomiainen [Finlande] ; Kyosti A. Sotaniemi [Finlande] ; Vilho V. Myllyl [Finlande] | [123I]β-CIT SPECT demonstrates decreased brain dopamine and serotonin transporter levels in untreated parkinsonian patients |
| 002A50 |
Christopher J. Earley [États-Unis] ; Keith Hyland [États-Unis] ; Richard P. Allen [États-Unis] | CSF dopamine, serotonin, and biopterin metabolites in patients with Restless Legs Syndrome |
| 002A63 |
José A. Dominguez-Moran [Espagne] ; Juan M. Callejo [Espagne] ; Luis C. Fernandez-Ruiz [Espagne] ; Juan C. Martinez-Castrillo [Espagne] | Acute paroxysmal dystonia induced by fluoxetine |
| 002A91 |
Silvana Tesei [Italie] ; Angelo Antonini [Italie] ; Margherita Canesi [Italie] ; Anna Zecchinelli [Italie] ; Claudio B. Mariani [Italie] ; Gianni Pezzoli [Italie] | Tolerability of paroxetine in Parkinson's disease : A prospective study |
| 002D25 |
D. Mathen [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] ; K. P. Bhatia [Royaume-Uni] | SSRI-induced reversal of levodopa benefit in two patients with dopa-responsive dystonia |
| 002E36 |
I. H. Richard [États-Unis] ; A. Maughn [États-Unis] ; R. Kurlan [États-Unis] | Do serotonin reuptake inhibitor antidepressants worsen Parkinson's disease? A retrospective case series |
| 003054 |
I. M. Bronner [Pays-Bas] ; J. A. L. Vanneste [Pays-Bas] | Complex movement disorder associated with fluvoxamine |
| 003089 |
R. Kurlan [États-Unis] | Acute parkinsonism induced by the combination of a serotonin reuptake inhibitor and a neuroleptic in adults with Tourette's syndrome |
| 003144 |
M. Poyurovsky [Israël] ; M. Schneidman [Israël] ; A. Weizman [Israël] | Successful treatment of fluoxetine-induced dystonia with low-dose mianserin |
| 003157 |
R. A. Hauser [États-Unis] ; T. A. Zesiewicz [États-Unis] | Sertraline for the treatment of depression in Parkinson's disease |
| 003295 |
P. G. Como [États-Unis] ; A. J. Rubin [États-Unis] ; C. F. O'Brien [États-Unis] ; K. Lawler [États-Unis] ; C. Hickey [États-Unis] ; A. E. Rubin [États-Unis] ; R. Henderson [États-Unis] ; M. P. Mcdermott [États-Unis] ; T. Mcdermott [États-Unis] ; K. Steinberg [États-Unis] ; I. Shoulson [États-Unis] | A controlled trial of fluoxetine in nondepressed patients with Huntington's disease |
| 003387 |
K. J. Bharucha [États-Unis] ; K. D. Sethi [États-Unis] | Complex movement disorders induced by fluoxetine |
| 003577 |
E. C. Lauterbach [États-Unis] | Reversible intermittent rhythmic myoclonus with fluoxetine in presumed Pick's disease |
| 003947 |
C. G. Goetz ; C. M. Tanner | Gilles de la Tourette's syndrome in twins: clinical and neurochemical data |
| 003A28 |
R. Mayeux ; Y. Stern ; M. Sano ; J. B. W. Williams ; L. J. Cote | The relationship of serotonin to depression in Parkinson's disease |
